SINOPHARM CAPITAL
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and is based in Shanghai, China.
SINOPHARM CAPITAL
Social Links:
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
2012-06-01
Status:
Active
Contact:
86 21 6333 7900
Email Addresses:
[email protected]
Technology used in webpage:
GlobalSign Alibaba Tengine HiChina
Similar Organizations
Color Capital
Color Capital invests in things people buy, and how they buy them.
Oceanpine Capital
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-23 | MXB Biotechnologies | MXB Biotechnologies acquired by Sinopharm Capital | 2.63 B CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | Metanovas | Sinopharm Capital investment in Seed Round - Metanovas | 10 M USD |
| 2022-03-31 | Artivila Therapeutics | Sinopharm Capital investment in Seed Round - Artivila Therapeutics | 100 M CNY |
| 2021-12-13 | Xishan | Sinopharm Capital investment in Series D - Xishan | 100 M CNY |
| 2021-12-07 | Sumgen Biotech | Sinopharm Capital investment in Venture Round - Sumgen Biotech | N/A |
| 2021-11-26 | Longhui Medical | Sinopharm Capital investment in Series B - Longhui Medical | 100 M CNY |
| 2021-11-15 | Sepax Technologies | Sinopharm Capital investment in Series D - Sepax Technologies | 500 M CNY |
| 2021-11-02 | Shanghai Ouyi Biomedical Technology | Sinopharm Capital investment in Series A - Shanghai Ouyi Biomedical Technology | 100 M CNY |
| 2021-10-01 | Brise Pharma | Sinopharm Capital investment in Angel Round - Brise Pharma | 150 M CNY |
| 2021-09-28 | Geneus | Sinopharm Capital investment in Series B - Geneus | N/A |
| 2021-05-06 | Yikon Genomics | Sinopharm Capital investment in Series D - Yikon Genomics | 250 M CNY |
More informations about "Sinopharm Capital"
Sinopharm Capital Portfolio Companies - Crunchbase
Jul 2, 2012 Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation. This list of organizations invested in by Sinopharm Capital provides data on their โฆSee details»
Sinopharm Capital - Investments, Portfolio & Company Exits
Sinopharm Capital 's most notable exits include Abbisko Therapeutics, InventisBio, and Semma Therapeutics. Which industries has this organization had the most exits in? Show . Abbisko โฆSee details»
Sinopharm Capital investment portfolio | PitchBook
Sinopharm Capital General Information Company Description. Sinopharm Capital is a venture capital arm of Sinopharm Group focusing on medical and health fields. The firm is primarily based in Shanghai, China and prefers to invest in โฆSee details»
Sinopharm CICC investment portfolio | PitchBook
Sinopharm CICC General Information Company Description. Founded in 2016, Sinopharm CICC is a private equity investment fund management company based in Shanghai, China. The company was jointly initiated and established โฆSee details»
Sinopharm Capital | Institution Profile - Private Equity International
Sinopharm Capital contact information Offices 16th Floor, No.266, Hankou Road, Huangpu District,, Shanghai, 200001, China Showing 1 of 1 Sinopharm Capital officesSee details»
Sinopharm Capital Management Co Ltd - Company Profile and News
Company profile page for Sinopharm Capital Management Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
Sinopharm capital officially changed its name to "Jianyi capital" โฆ
Jan 19, 2022 On the 19th, yiouda health learned that the former Sinopharm capital held the "Jianyi capital 2021 fund Partner Conference and new brand press conference" in Shanghai, โฆSee details»
Sinopharm (company) - Wikipedia
China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise.The corporation was the indirect major โฆSee details»
China's Sinopharm to extend its reach into Southeast Asia
Jun 21, 2019 SINGAPORE -- Sinopharm Capital will launch a $150 million investment fund to tap into the growing Southeast Asian healthcare market. The private equity arm of state โฆSee details»
Sinopharm Is the Largest Drugs and Medical Devices
Feb 14, 2024 Hence, Sinopharm may need to refinance its receivables by selling to third parties or take debt financing to replenish its working capital. As such, financing cost is another โฆSee details»
Sinopharm Capital - Funding, Financials, Valuation & Investors
Sinopharm Capital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 1. Funding. Sinopharm โฆSee details»
Sinopharm Group: The Focus Is On Working Capital And Profitability
Nov 21, 2024 Sinopharm Group's days sales outstanding increased from 116 days in Q4 2023 to 132 days in Q1 2024, before rising further to 150 days for both Q2 2024 and Q3 2024 as per โฆSee details»
Sinopharm Company Profile, Stock Price, News, Rankings - Fortune
Sinopharm in Fortune Rankings. 112 Fortune Global 500. Company Information Key Financials (last Fiscal Year) Profit Ratios. Company Information. Company Information;See details»
WHO approval of Sinopharm vaccine set to benefit world โฆ
May 10, 2021 The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health โฆSee details»
Sinopharm: Chinese Covid vaccine gets WHO emergency approval โฆ
May 7, 2021 The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine โฆSee details»
Sinopharm Capital - Updates, News, Events, Signals & Triggers
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation.See details»
WHO approves China's Sinopharm vaccine for emergency use
May 8, 2021 The Sinopharm vaccine joins a list of WHO approved vaccines, in addition to those made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. "The addition of this vaccine โฆSee details»
Paris dreams of becoming the capital of positive AI with the ...
1 day ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»
Sinopharm-CICC - Crunchbase Investor Profile & Investments
Also Known As Yaojin Capital, Yaojin (Shanghai) Private Equity, Sinopharm Zhongjin, ๅฝ่ฏไธญ้, ๆ้๏ผไธๆตท๏ผ็งๅๅบ้็ฎก็ๆ้ๅ ฌๅธ, ไธญ้็งๅ; Legal Name Yaojin (Shanghai) Private โฆSee details»
US Coast Guard is searching for 5 people after a fishing boat ...
15 hours ago The U.S. Coast Guard says itโs searching for five people after a fishing boat reportedly capsized in rough weather and cold seas southwest of Alaska's capital city of โฆSee details»